Rigel Pharmaceuticals | Attività Correnti

Current Assets Cambiamento Data
Amgen USD 30.33B 18.14B 2023-12
Arrowhead Research USD 237.9M 181.62M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Celldex Therapeutics USD 431.69M 185.76M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Veracyte USD 285.62M 14.46M 2023-12



Rigel Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.